Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
KYNB
$5.24
-0.76%
KYNB
· Kyntra Bio, Inc.
Market Cap
$21.38M
Shares
4.05M
Volume · Oct 21
7418
Avg daily vol (3M)
19.56K
All webcasts
Earnings call · FY2021 Q3
Kyntra Bio, Inc. (KYNB) Q3 2021 Earnings Call
Revenue
$155.97M
+254.2% YoY
Diluted EPS
$13.50
+54.3% YoY
Net income
$49.80M
+50.9% YoY
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 9, 2021.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Ending balance of cash, cash equivalents, investments, and accou
2021
|
$580M – $610M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2021 · complete as-filed document